Drug policies have traditionally sought to suppress supply and deter use through the application of punitive laws. Today, there is a growing recognition that these drug policies have not only failed to reach their objectives but have resulted in a great deal of collateral damage. Drug policy must be reformed to focus on health, human rights and development objectives, with the aim of making the market less harmful rather than necessarily reducing its size.
The President of the International Narcotics Control Board (INCB), Raymond Yans, has voiced concern about the outcome of recent referenda in the USA that would allow the non-medical use of cannabis by adults in Colorado and Washington.
How did the international drug control system arise, why has it proven so durable in the face of failure, and is there hope for reform? These are the questions that were discussed at the October event organised by LSE.
In October, the African Union hosted the 5th Conference of Ministers of Drug Control in Addis Ababa. IDPC was present throughout the four-day meeting, during which Member States adopted and approved important drug policy documents for the region.
At this year’s annual Union of British Columbian Municipalities convention on September 26th passed a resolution calling on the government to decriminalize marijuana and research its regulation and taxation. The motion supports the decriminalization of marijuana and pushes higher levels of…
In this report, the UK Drug Policy Commission identifies a fresh approach to drug policy, with both a recasting of how it structures its response to drug problems, and an analysis of the evidence for how policies and interventions could be improved.